Founded in 2013 by former New York City Deputy Mayor and CEO of Sidewalk Labs, Dan Doctoroff with support from Bloomberg Philanthropies, Target ALS is a non-profit foundation focused on fostering collaboration to accelerate ALS drug discovery and development. 

Non Profit

Target ALS

Manish Raisinghani

Eric Schaeffer

Ian Reynolds

Carole Ho

Kelly Monk

Zach Hall

Richard Hargreaves

Andy Berndt

Tracy Saxton

Stacie Weninger

Zaven Kaprielian

Rob Scannevin

Michael Ahlijanian

Kimberly Scearce - Levie

Kenneth Devaney

Jim Kupiec

Yuliya Rzad

The Research and Development Team at Target ALS is dedicated to advancing innovative drug discovery and development for Amyotrophic Lateral Sclerosis (ALS). This team collaborates across scientific disciplines, focusing on translational science, clinical neuroimaging, precision medicine, and cutting-edge research in neuroscience and rare diseases, to progress towards effective treatments and a cure for ALS.

Research and Development Team

Leadership Team

Research and Development Team

About

Team members

Other teams at Target ALS

Leadership Team